Introduction of the reference price (TFR) for drugs in generic groups
Article 43 of the 2003 Social Security Financing Act allows the reimbursement base of drugs in a generic group to be capped at a flat reference price set by ministers, whether the patient chooses the originator or the generic; pharmacists' discounts are capped at 2.5% (6% until 30 June 2004). The first reference prices applied from 8 September 2003.
Measure originators
No official estimate found for this measure.
Measure impact
Since 8 September 2003 a patient choosing an originator drug subject to a reference price is reimbursed on the generic group's reference price and pays the difference.
Official references
Sources
Procedure timeline
Follow the progress of this fiscal measure through the different stages of the parliamentary procedure.
Administrative implementation
EntrĂ©e en vigueur de la mesure et mise en Ćuvre par l'administration
Entry into force
Immédiate ou à la date prévue
Publication in Official Journal
President of the Republic signature
Publication au Journal officiel
Possible referral to Constitutional Council
Décision de conformité / censure partielle
National Assembly has the final say
Si échec CMP
Debate and vote
Débat et vote en séance publique à l'Assemblée nationale, ou engagement de la responsabilité du Gouvernement (article 49.3)